Treatment Adherence and Blood Pressure Outcome Among Hypertensive Out-patients
1 other identifier
observational
605
1 country
1
Brief Summary
It is estimated that more than 70% of patients on antihypertensive medications do not take them as prescribed. Treatment non-adherence practice may be particularly higher in developing countries where there is poor accessibility to medicines and healthcare services, coupled with low level of awareness of the lifelong nature of hypertension treatment among patients. Optimal control of blood pressure has been reported to reduce the incidence of morbidity and mortality associated with hypertension. Thus, adoption of healthy lifestyle as well as ensuring regular and continuous adherence to prescribed medications are integral to successful management of hypertension to achieve the target blood pressure goals. The present study comprehensively evaluated adherence to pharmacotherapy and non-pharmacological measures among ambulatory hypertensive patients attending two healthcare institutions in Sokoto, Northwestern Nigeria. Reasons for treatment non-adherence were evaluated, while perception and beliefs about hypertension and its management were also explored, with pharmacist-led patient-specific adherence education provided as appropriate to resolve the knowledge gap(s). Association between treatment adherence and blood pressure outcome at contact and the subsequent 2-months clinic appointment were investigated. Patients aged 18 years and above, with a primary diagnosis of hypertension, and who were on antihypertensive medications for at least 3-months were recruited from the medical outpatient clinic of Usmanu Danfodiyo University Teaching Hospital and the Specialist Hospital, both within Sokoto metropolis, Sokoto state, Northwestern Nigeria. Newly diagnosed patients, in-patients and those who declined participation were excluded from the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2017
CompletedFirst Submitted
Initial submission to the registry
February 28, 2018
CompletedFirst Posted
Study publicly available on registry
March 26, 2018
CompletedMarch 26, 2018
March 1, 2018
4 months
February 28, 2018
March 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Questionnaire with a nine-item adherence scale to assess the level of adherence to medication
Questionnaire with a nine-item adherence scale was used to assess the level of adherence to medication, while dichotomous Yes/No response option was used to evaluate the level of adherence to the 4-domains of non-pharmacological lifestyle modifications, specifically smoking, alcohol, exercise, and salt-restriction. Using the Statistical Package for Social Sciences version 22 at p \< 0.05 level of significance, descriptive statistics including frequency and percentage was used to summarise the data on these parameters
5 hours on Thursday clinic days, 16 weeks
Secondary Outcomes (2)
Perception and belief about hypertension and treatment
5 hours on Thursday clinic days, 16 weeks
Data collection form to retrieve the average of two consecutive blood pressure readings (Systolic and Diastolic)
4 hours on Thursday clinic days, 16 weeks
Interventions
Patients were given adherence education to resolve the identified deficits
Eligibility Criteria
Ambulatory hypertensive patients
You may qualify if:
- Patients aged 18 years and above, with a primary diagnosis of hypertension, and who were on antihypertensive medications for at least 3-months were enrolled.
You may not qualify if:
- Newly diagnosed patients, in-patients and those who declined participation were excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Usmanu Danfodiyo University Teaching Hospital
Sokoto, 840252, Nigeria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Medication Therapy Management Research in Communicable and non-communicable
Study Record Dates
First Submitted
February 28, 2018
First Posted
March 26, 2018
Study Start
February 1, 2017
Primary Completion
May 30, 2017
Study Completion
May 30, 2017
Last Updated
March 26, 2018
Record last verified: 2018-03